Share Price and Basic Stock Data
Last Updated: December 19, 2025, 8:09 pm
| PEG Ratio | 1.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Banco Products (India) Ltd operates in the auto ancillaries sector, specifically focusing on manufacturing engine parts. The company has showcased a commendable growth trajectory, with total sales rising from ₹1,958 Cr in FY 2022 to ₹2,332 Cr in FY 2023, marking a robust year-on-year increase. The revenue trend appears promising, with the trailing twelve months (TTM) sales reported at ₹3,379 Cr, reflecting a continuous upward momentum. Moreover, the latest quarterly sales figures indicate a healthy demand, with ₹749 Cr recorded in June 2023 and ₹724 Cr in September 2023. Even more encouraging is the projection of ₹3,213 Cr for FY 2025, which suggests that Banco is well-positioned to capitalize on the growing automotive market in India. This growth is underpinned by increasing vehicle production and a shift towards more fuel-efficient technologies, aligning with broader industry trends.
Profitability and Efficiency Metrics
Banco Products has exhibited strong profitability metrics, with a reported net profit of ₹433 Cr for FY 2025, up from ₹236 Cr in FY 2023. This impressive growth in profitability is complemented by a healthy return on equity (ROE) of 32.2% and return on capital employed (ROCE) of 32.4%, both of which indicate efficient utilization of capital. The operating profit margin (OPM) stood at 19% in FY 2025, showcasing the company’s ability to maintain operational efficiency despite rising costs. However, the cash conversion cycle (CCC) of 231 days raises some eyebrows; while this figure is not excessively high, it indicates that capital is tied up for a considerable time before being converted into cash. Balancing operational efficiency with working capital management will be crucial for sustaining profitability in the future.
Balance Sheet Strength and Financial Ratios
Banco’s balance sheet reflects a sound financial position, characterized by total assets of ₹2,744 Cr and a manageable level of borrowings at ₹729 Cr. The debt-to-equity ratio stands at a comfortable 0.24, suggesting that the company is not overly reliant on debt to finance its operations. Furthermore, the interest coverage ratio (ICR) is exceptionally strong at 25.52x, indicating that Banco can comfortably meet its interest obligations. With reserves amounting to ₹1,606 Cr, the company appears well-capitalized for future growth initiatives. However, the price-to-book (P/BV) ratio at 3.79x suggests that the stock may be trading at a premium, which could deter some value-oriented investors. Thus, while the balance sheet is robust, potential investors should exercise caution regarding valuation levels.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Banco Products reveals a significant level of promoter confidence, with promoters holding 67.88% of the equity. This steady ownership signals a strong alignment of interests between management and shareholders. However, institutional interest remains modest, with foreign institutional investors (FIIs) at 4.40% and domestic institutional investors (DIIs) at a mere 0.29%. This limited institutional engagement may suggest a lack of widespread recognition among larger investors, which could impact liquidity. The number of shareholders has grown from 43,180 in December 2022 to 72,708 in September 2025, indicating increasing retail interest. This growing retail base could provide stability and support for the stock, but it also raises questions about the sustainability of this interest in the face of market fluctuations.
Outlook, Risks, and Final Insight
Looking ahead, Banco Products seems well-positioned to leverage the expanding automotive sector, particularly with the ongoing shift towards electric and hybrid vehicles. However, investors should remain vigilant regarding potential risks, such as rising raw material costs and supply chain disruptions, which could impact margins. Additionally, the company’s relatively high cash conversion cycle might pose liquidity challenges if not managed effectively. Overall, while Banco Products displays several strengths—strong financial metrics, robust profitability, and a solid balance sheet—investors must weigh these against the backdrop of industry volatility and broader economic conditions. As always, a prudent approach that considers both the opportunities and risks is essential for making informed investment decisions.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| IP Rings Ltd | 144 Cr. | 114 | 212/108 | 80.2 | 0.00 % | 3.08 % | 4.14 % | 10.0 | |
| Talbros Automotive Components Ltd | 1,719 Cr. | 278 | 338/200 | 18.0 | 110 | 0.25 % | 19.3 % | 15.9 % | 2.00 |
| Sundram Fasteners Ltd | 19,761 Cr. | 940 | 1,134/831 | 35.7 | 193 | 0.77 % | 17.1 % | 14.9 % | 1.00 |
| Sintercom India Ltd | 285 Cr. | 104 | 184/99.0 | 285 | 37.1 | 0.00 % | 5.08 % | 0.66 % | 10.0 |
| Shriram Pistons & Rings Ltd | 13,617 Cr. | 3,086 | 3,260/1,556 | 25.2 | 599 | 0.32 % | 25.7 % | 23.2 % | 10.0 |
| Industry Average | 13,003.75 Cr | 3,532.38 | 53.64 | 554.76 | 0.65% | 16.53% | 14.30% | 7.25 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 586 | 628 | 509 | 609 | 749 | 725 | 571 | 724 | 804 | 895 | 639 | 875 | 970 |
| Expenses | 519 | 569 | 369 | 511 | 653 | 602 | 482 | 610 | 671 | 689 | 581 | 660 | 788 |
| Operating Profit | 67 | 59 | 140 | 98 | 97 | 122 | 89 | 114 | 133 | 206 | 58 | 214 | 182 |
| OPM % | 11% | 9% | 28% | 16% | 13% | 17% | 16% | 16% | 17% | 23% | 9% | 24% | 19% |
| Other Income | 1 | 10 | 1 | 3 | 16 | 3 | 12 | 6 | 2 | 17 | 5 | 19 | 14 |
| Interest | 2 | 1 | 3 | 7 | 5 | 6 | 4 | 7 | 7 | 6 | 5 | 8 | 7 |
| Depreciation | 12 | 12 | 13 | 20 | 15 | 16 | 17 | 28 | 19 | 19 | 20 | 36 | 24 |
| Profit before tax | 55 | 56 | 126 | 74 | 93 | 104 | 81 | 86 | 109 | 197 | 39 | 190 | 164 |
| Tax % | 37% | 8% | 22% | 31% | 26% | 36% | 15% | 20% | 37% | 30% | 21% | 19% | 33% |
| Net Profit | 35 | 52 | 98 | 51 | 69 | 66 | 68 | 68 | 69 | 139 | 31 | 154 | 110 |
| EPS in Rs | 2.42 | 3.62 | 6.87 | 3.57 | 4.81 | 4.62 | 4.78 | 4.77 | 4.80 | 9.70 | 2.16 | 10.73 | 7.66 |
Last Updated: August 20, 2025, 1:05 pm
Below is a detailed analysis of the quarterly data for Banco Products (India) Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 970.00 Cr.. The value appears strong and on an upward trend. It has increased from 875.00 Cr. (Mar 2025) to 970.00 Cr., marking an increase of 95.00 Cr..
- For Expenses, as of Jun 2025, the value is 788.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 660.00 Cr. (Mar 2025) to 788.00 Cr., marking an increase of 128.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 182.00 Cr.. The value appears to be declining and may need further review. It has decreased from 214.00 Cr. (Mar 2025) to 182.00 Cr., marking a decrease of 32.00 Cr..
- For OPM %, as of Jun 2025, the value is 19.00%. The value appears to be declining and may need further review. It has decreased from 24.00% (Mar 2025) to 19.00%, marking a decrease of 5.00%.
- For Other Income, as of Jun 2025, the value is 14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 19.00 Cr. (Mar 2025) to 14.00 Cr., marking a decrease of 5.00 Cr..
- For Interest, as of Jun 2025, the value is 7.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 8.00 Cr. (Mar 2025) to 7.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 24.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 36.00 Cr. (Mar 2025) to 24.00 Cr., marking a decrease of 12.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 164.00 Cr.. The value appears to be declining and may need further review. It has decreased from 190.00 Cr. (Mar 2025) to 164.00 Cr., marking a decrease of 26.00 Cr..
- For Tax %, as of Jun 2025, the value is 33.00%. The value appears to be increasing, which may not be favorable. It has increased from 19.00% (Mar 2025) to 33.00%, marking an increase of 14.00%.
- For Net Profit, as of Jun 2025, the value is 110.00 Cr.. The value appears to be declining and may need further review. It has decreased from 154.00 Cr. (Mar 2025) to 110.00 Cr., marking a decrease of 44.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 7.66. The value appears to be declining and may need further review. It has decreased from 10.73 (Mar 2025) to 7.66, marking a decrease of 3.07.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:35 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,116 | 1,129 | 1,148 | 1,239 | 1,336 | 1,567 | 1,422 | 1,533 | 1,958 | 2,332 | 2,768 | 3,213 | 3,522 |
| Expenses | 951 | 1,027 | 1,002 | 1,096 | 1,157 | 1,405 | 1,300 | 1,354 | 1,686 | 1,966 | 2,340 | 2,601 | 2,918 |
| Operating Profit | 165 | 102 | 146 | 144 | 179 | 161 | 122 | 178 | 272 | 366 | 428 | 611 | 604 |
| OPM % | 15% | 9% | 13% | 12% | 13% | 10% | 9% | 12% | 14% | 16% | 15% | 19% | 17% |
| Other Income | 9 | 53 | 11 | 32 | 18 | 10 | 25 | 9 | 5 | 14 | 32 | 43 | 96 |
| Interest | 19 | 8 | 3 | 2 | 2 | 4 | 3 | 4 | 5 | 13 | 21 | 26 | 28 |
| Depreciation | 32 | 34 | 35 | 33 | 28 | 29 | 33 | 34 | 48 | 56 | 76 | 94 | 105 |
| Profit before tax | 122 | 113 | 119 | 141 | 167 | 138 | 111 | 150 | 224 | 311 | 363 | 534 | 568 |
| Tax % | 26% | 22% | 25% | 31% | 30% | 50% | 31% | 24% | 32% | 24% | 25% | 27% | |
| Net Profit | 90 | 88 | 90 | 97 | 117 | 69 | 77 | 114 | 152 | 236 | 271 | 392 | 433 |
| EPS in Rs | 6.28 | 6.13 | 6.29 | 6.80 | 8.17 | 4.83 | 5.36 | 7.95 | 10.66 | 16.47 | 18.98 | 27.39 | 30.26 |
| Dividend Payout % | 16% | 24% | 37% | 66% | 61% | 83% | 187% | 13% | 94% | 67% | 53% | 40% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -2.22% | 2.27% | 7.78% | 20.62% | -41.03% | 11.59% | 48.05% | 33.33% | 55.26% | 14.83% | 44.65% |
| Change in YoY Net Profit Growth (%) | 0.00% | 4.49% | 5.51% | 12.84% | -61.64% | 52.62% | 36.46% | -14.72% | 21.93% | -40.43% | 29.82% |
Banco Products (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 18% |
| 3 Years: | 18% |
| TTM: | 20% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 39% |
| 3 Years: | 36% |
| TTM: | 60% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 67% |
| 3 Years: | 68% |
| 1 Year: | 80% |
| Return on Equity | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 24% |
| 3 Years: | 28% |
| Last Year: | 32% |
Last Updated: September 5, 2025, 12:30 am
Balance Sheet
Last Updated: December 4, 2025, 1:01 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 29 | 29 |
| Reserves | 574 | 605 | 674 | 705 | 793 | 818 | 696 | 814 | 967 | 987 | 1,037 | 1,274 | 1,606 |
| Borrowings | 172 | 36 | 36 | 38 | 34 | 40 | 92 | 14 | 115 | 418 | 423 | 573 | 729 |
| Other Liabilities | 183 | 164 | 232 | 211 | 356 | 322 | 287 | 344 | 405 | 435 | 508 | 868 | 714 |
| Total Liabilities | 944 | 819 | 956 | 969 | 1,197 | 1,195 | 1,089 | 1,187 | 1,502 | 1,855 | 1,982 | 2,744 | 3,078 |
| Fixed Assets | 243 | 227 | 221 | 192 | 191 | 184 | 193 | 190 | 297 | 359 | 454 | 516 | 484 |
| CWIP | 12 | 11 | 3 | 4 | 13 | 13 | 3 | 1 | 15 | 18 | 10 | 5 | 16 |
| Investments | 71 | 1 | 1 | 91 | 24 | 69 | 9 | 1 | 1 | 0 | 0 | 38 | 76 |
| Other Assets | 618 | 581 | 731 | 682 | 969 | 929 | 883 | 995 | 1,190 | 1,477 | 1,518 | 2,185 | 2,501 |
| Total Assets | 944 | 819 | 956 | 969 | 1,197 | 1,195 | 1,089 | 1,187 | 1,502 | 1,855 | 1,982 | 2,744 | 3,078 |
Below is a detailed analysis of the balance sheet data for Banco Products (India) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 29.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 29.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,606.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,274.00 Cr. (Mar 2025) to 1,606.00 Cr., marking an increase of 332.00 Cr..
- For Borrowings, as of Sep 2025, the value is 729.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 573.00 Cr. (Mar 2025) to 729.00 Cr., marking an increase of 156.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 714.00 Cr.. The value appears to be improving (decreasing). It has decreased from 868.00 Cr. (Mar 2025) to 714.00 Cr., marking a decrease of 154.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 3,078.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,744.00 Cr. (Mar 2025) to 3,078.00 Cr., marking an increase of 334.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 484.00 Cr.. The value appears to be declining and may need further review. It has decreased from 516.00 Cr. (Mar 2025) to 484.00 Cr., marking a decrease of 32.00 Cr..
- For CWIP, as of Sep 2025, the value is 16.00 Cr.. The value appears strong and on an upward trend. It has increased from 5.00 Cr. (Mar 2025) to 16.00 Cr., marking an increase of 11.00 Cr..
- For Investments, as of Sep 2025, the value is 76.00 Cr.. The value appears strong and on an upward trend. It has increased from 38.00 Cr. (Mar 2025) to 76.00 Cr., marking an increase of 38.00 Cr..
- For Other Assets, as of Sep 2025, the value is 2,501.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,185.00 Cr. (Mar 2025) to 2,501.00 Cr., marking an increase of 316.00 Cr..
- For Total Assets, as of Sep 2025, the value is 3,078.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,744.00 Cr. (Mar 2025) to 3,078.00 Cr., marking an increase of 334.00 Cr..
Notably, the Reserves (1,606.00 Cr.) exceed the Borrowings (729.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -7.00 | 66.00 | 110.00 | 106.00 | 145.00 | 121.00 | 30.00 | 164.00 | 157.00 | -52.00 | 5.00 | 38.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 70 | 57 | 70 | 60 | 70 | 63 | 75 | 64 | 60 | 65 | 63 | 69 |
| Inventory Days | 172 | 152 | 190 | 171 | 217 | 191 | 212 | 234 | 225 | 271 | 210 | 289 |
| Days Payable | 57 | 39 | 71 | 51 | 90 | 102 | 99 | 118 | 95 | 95 | 90 | 128 |
| Cash Conversion Cycle | 184 | 170 | 189 | 180 | 197 | 152 | 188 | 180 | 191 | 241 | 183 | 231 |
| Working Capital Days | 71 | 103 | 107 | 105 | 108 | 111 | 120 | 132 | 133 | 123 | 102 | 106 |
| ROCE % | 19% | 12% | 18% | 17% | 21% | 17% | 13% | 19% | 24% | 26% | 27% | 32% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 27.39 | 37.95 | 32.94 | 21.31 | 15.90 |
| Diluted EPS (Rs.) | 27.39 | 37.95 | 32.94 | 21.31 | 15.90 |
| Cash EPS (Rs.) | 33.99 | 48.57 | 40.82 | 28.00 | 20.61 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 91.05 | 146.95 | 139.96 | 137.19 | 115.76 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 91.08 | 147.03 | 140.03 | 137.27 | 115.83 |
| Revenue From Operations / Share (Rs.) | 224.59 | 387.09 | 326.04 | 273.78 | 214.29 |
| PBDIT / Share (Rs.) | 45.74 | 64.33 | 53.10 | 38.72 | 26.17 |
| PBIT / Share (Rs.) | 39.14 | 53.70 | 45.22 | 32.02 | 21.46 |
| PBT / Share (Rs.) | 37.35 | 50.71 | 43.46 | 31.29 | 20.95 |
| Net Profit / Share (Rs.) | 27.39 | 37.95 | 32.94 | 21.31 | 15.90 |
| NP After MI And SOA / Share (Rs.) | 27.39 | 37.95 | 32.94 | 21.31 | 15.90 |
| PBDIT Margin (%) | 20.36 | 16.61 | 16.28 | 14.14 | 12.21 |
| PBIT Margin (%) | 17.42 | 13.87 | 13.86 | 11.69 | 10.01 |
| PBT Margin (%) | 16.62 | 13.10 | 13.32 | 11.42 | 9.77 |
| Net Profit Margin (%) | 12.19 | 9.80 | 10.10 | 7.78 | 7.42 |
| NP After MI And SOA Margin (%) | 12.19 | 9.80 | 10.10 | 7.78 | 7.42 |
| Return on Networth / Equity (%) | 30.08 | 25.82 | 23.53 | 15.53 | 13.73 |
| Return on Capital Employeed (%) | 32.38 | 28.32 | 26.21 | 19.63 | 16.89 |
| Return On Assets (%) | 13.76 | 13.38 | 12.50 | 9.95 | 9.35 |
| Long Term Debt / Equity (X) | 0.01 | 0.03 | 0.03 | 0.01 | 0.01 |
| Total Debt / Equity (X) | 0.24 | 0.21 | 0.29 | 0.02 | 0.01 |
| Asset Turnover Ratio (%) | 1.32 | 1.42 | 0.84 | 0.79 | 0.70 |
| Current Ratio (X) | 1.98 | 2.24 | 2.24 | 3.17 | 3.21 |
| Quick Ratio (X) | 0.74 | 0.86 | 0.70 | 1.20 | 1.37 |
| Inventory Turnover Ratio (X) | 2.79 | 1.59 | 1.31 | 1.39 | 1.21 |
| Dividend Payout Ratio (NP) (%) | 40.15 | 89.59 | 24.28 | 9.38 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 32.36 | 69.99 | 19.59 | 7.14 | 0.00 |
| Earning Retention Ratio (%) | 59.85 | 10.41 | 75.72 | 90.62 | 0.00 |
| Cash Earning Retention Ratio (%) | 67.64 | 30.01 | 80.41 | 92.86 | 0.00 |
| Interest Coverage Ratio (X) | 25.52 | 21.54 | 30.18 | 52.69 | 51.73 |
| Interest Coverage Ratio (Post Tax) (X) | 16.29 | 13.70 | 19.72 | 30.00 | 32.44 |
| Enterprise Value (Cr.) | 5131.35 | 4411.67 | 1882.76 | 913.42 | 896.66 |
| EV / Net Operating Revenue (X) | 1.60 | 1.59 | 0.80 | 0.46 | 0.58 |
| EV / EBITDA (X) | 7.84 | 9.59 | 4.96 | 3.30 | 4.79 |
| MarketCap / Net Operating Revenue (X) | 1.54 | 1.54 | 0.69 | 0.49 | 0.65 |
| Retention Ratios (%) | 59.84 | 10.40 | 75.71 | 90.61 | 0.00 |
| Price / BV (X) | 3.79 | 4.05 | 1.61 | 0.99 | 1.21 |
| Price / Net Operating Revenue (X) | 1.54 | 1.54 | 0.69 | 0.49 | 0.65 |
| EarningsYield | 0.07 | 0.06 | 0.14 | 0.15 | 0.11 |
After reviewing the key financial ratios for Banco Products (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 27.39. This value is within the healthy range. It has decreased from 37.95 (Mar 24) to 27.39, marking a decrease of 10.56.
- For Diluted EPS (Rs.), as of Mar 25, the value is 27.39. This value is within the healthy range. It has decreased from 37.95 (Mar 24) to 27.39, marking a decrease of 10.56.
- For Cash EPS (Rs.), as of Mar 25, the value is 33.99. This value is within the healthy range. It has decreased from 48.57 (Mar 24) to 33.99, marking a decrease of 14.58.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.05. It has decreased from 146.95 (Mar 24) to 91.05, marking a decrease of 55.90.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.08. It has decreased from 147.03 (Mar 24) to 91.08, marking a decrease of 55.95.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 224.59. It has decreased from 387.09 (Mar 24) to 224.59, marking a decrease of 162.50.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 45.74. This value is within the healthy range. It has decreased from 64.33 (Mar 24) to 45.74, marking a decrease of 18.59.
- For PBIT / Share (Rs.), as of Mar 25, the value is 39.14. This value is within the healthy range. It has decreased from 53.70 (Mar 24) to 39.14, marking a decrease of 14.56.
- For PBT / Share (Rs.), as of Mar 25, the value is 37.35. This value is within the healthy range. It has decreased from 50.71 (Mar 24) to 37.35, marking a decrease of 13.36.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 27.39. This value is within the healthy range. It has decreased from 37.95 (Mar 24) to 27.39, marking a decrease of 10.56.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 27.39. This value is within the healthy range. It has decreased from 37.95 (Mar 24) to 27.39, marking a decrease of 10.56.
- For PBDIT Margin (%), as of Mar 25, the value is 20.36. This value is within the healthy range. It has increased from 16.61 (Mar 24) to 20.36, marking an increase of 3.75.
- For PBIT Margin (%), as of Mar 25, the value is 17.42. This value is within the healthy range. It has increased from 13.87 (Mar 24) to 17.42, marking an increase of 3.55.
- For PBT Margin (%), as of Mar 25, the value is 16.62. This value is within the healthy range. It has increased from 13.10 (Mar 24) to 16.62, marking an increase of 3.52.
- For Net Profit Margin (%), as of Mar 25, the value is 12.19. This value exceeds the healthy maximum of 10. It has increased from 9.80 (Mar 24) to 12.19, marking an increase of 2.39.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 12.19. This value is within the healthy range. It has increased from 9.80 (Mar 24) to 12.19, marking an increase of 2.39.
- For Return on Networth / Equity (%), as of Mar 25, the value is 30.08. This value is within the healthy range. It has increased from 25.82 (Mar 24) to 30.08, marking an increase of 4.26.
- For Return on Capital Employeed (%), as of Mar 25, the value is 32.38. This value is within the healthy range. It has increased from 28.32 (Mar 24) to 32.38, marking an increase of 4.06.
- For Return On Assets (%), as of Mar 25, the value is 13.76. This value is within the healthy range. It has increased from 13.38 (Mar 24) to 13.76, marking an increase of 0.38.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.03 (Mar 24) to 0.01, marking a decrease of 0.02.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.24. This value is within the healthy range. It has increased from 0.21 (Mar 24) to 0.24, marking an increase of 0.03.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.32. It has decreased from 1.42 (Mar 24) to 1.32, marking a decrease of 0.10.
- For Current Ratio (X), as of Mar 25, the value is 1.98. This value is within the healthy range. It has decreased from 2.24 (Mar 24) to 1.98, marking a decrease of 0.26.
- For Quick Ratio (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 1. It has decreased from 0.86 (Mar 24) to 0.74, marking a decrease of 0.12.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.79. This value is below the healthy minimum of 4. It has increased from 1.59 (Mar 24) to 2.79, marking an increase of 1.20.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 40.15. This value is within the healthy range. It has decreased from 89.59 (Mar 24) to 40.15, marking a decrease of 49.44.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 32.36. This value is within the healthy range. It has decreased from 69.99 (Mar 24) to 32.36, marking a decrease of 37.63.
- For Earning Retention Ratio (%), as of Mar 25, the value is 59.85. This value is within the healthy range. It has increased from 10.41 (Mar 24) to 59.85, marking an increase of 49.44.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 67.64. This value is within the healthy range. It has increased from 30.01 (Mar 24) to 67.64, marking an increase of 37.63.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 25.52. This value is within the healthy range. It has increased from 21.54 (Mar 24) to 25.52, marking an increase of 3.98.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 16.29. This value is within the healthy range. It has increased from 13.70 (Mar 24) to 16.29, marking an increase of 2.59.
- For Enterprise Value (Cr.), as of Mar 25, the value is 5,131.35. It has increased from 4,411.67 (Mar 24) to 5,131.35, marking an increase of 719.68.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.60. This value is within the healthy range. It has increased from 1.59 (Mar 24) to 1.60, marking an increase of 0.01.
- For EV / EBITDA (X), as of Mar 25, the value is 7.84. This value is within the healthy range. It has decreased from 9.59 (Mar 24) to 7.84, marking a decrease of 1.75.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.54. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.54.
- For Retention Ratios (%), as of Mar 25, the value is 59.84. This value is within the healthy range. It has increased from 10.40 (Mar 24) to 59.84, marking an increase of 49.44.
- For Price / BV (X), as of Mar 25, the value is 3.79. This value exceeds the healthy maximum of 3. It has decreased from 4.05 (Mar 24) to 3.79, marking a decrease of 0.26.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.54. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.54.
- For EarningsYield, as of Mar 25, the value is 0.07. This value is below the healthy minimum of 5. It has increased from 0.06 (Mar 24) to 0.07, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Banco Products (India) Ltd:
- Net Profit Margin: 12.19%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 32.38% (Industry Average ROCE: 16.53%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 30.08% (Industry Average ROE: 14.3%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 16.29
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.74
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 23.3 (Industry average Stock P/E: 49.17)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.24
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 12.19%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Auto Ancl - Engine Parts | Bil, Near Bhaili Railway Station, Vadodra District Gujarat 391410 | investor@bancoindia.com http://www.bancoindia.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Mehul K Patel | Chairman |
| Mr. Venkata Ranganath Kumar Sami | Whole Time Director |
| Mr. Sharan M Patel | Whole Time Director |
| Mr. Shivam M Patel | Non Executive Director |
| Ms. Ameeta V Manohar | Independent Director |
| Mr. Tarak A Patel | Independent Director |
| Mr. Anand A Majmudar | Independent Director |
| Mr. Pranav R Patel | Independent Director |
FAQ
What is the intrinsic value of Banco Products (India) Ltd?
Banco Products (India) Ltd's intrinsic value (as of 19 December 2025) is 694.91 which is 1.29% lower the current market price of 704.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 10,075 Cr. market cap, FY2025-2026 high/low of 880/293, reserves of ₹1,606 Cr, and liabilities of 3,078 Cr.
What is the Market Cap of Banco Products (India) Ltd?
The Market Cap of Banco Products (India) Ltd is 10,075 Cr..
What is the current Stock Price of Banco Products (India) Ltd as on 19 December 2025?
The current stock price of Banco Products (India) Ltd as on 19 December 2025 is 704.
What is the High / Low of Banco Products (India) Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Banco Products (India) Ltd stocks is 880/293.
What is the Stock P/E of Banco Products (India) Ltd?
The Stock P/E of Banco Products (India) Ltd is 23.3.
What is the Book Value of Banco Products (India) Ltd?
The Book Value of Banco Products (India) Ltd is 114.
What is the Dividend Yield of Banco Products (India) Ltd?
The Dividend Yield of Banco Products (India) Ltd is 1.56 %.
What is the ROCE of Banco Products (India) Ltd?
The ROCE of Banco Products (India) Ltd is 32.4 %.
What is the ROE of Banco Products (India) Ltd?
The ROE of Banco Products (India) Ltd is 32.2 %.
What is the Face Value of Banco Products (India) Ltd?
The Face Value of Banco Products (India) Ltd is 2.00.